beamtx.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi BEAM
Beam Therapeutics Inc. (BEAM) relies on a secure liquidity buffer and the success of base editing genome technology. Tracking the chart on GURU.Markets, we note that EBITDA reached 0.00, reflecting the current level of this metric. The foundation consists of robotic therapy synthesis stations and the implementation of AI to accelerate molecular drug screening.
Beam Therapeutics (BEAM) - rincian metrik lan laporan keuangan
- kuotasi lan prakiraan analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Beam Therapeutics Inc.|BEAM - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Beam Therapeutics Inc|BEAM - Utang perusahaan|Rasio utang-utang marang kapitalisasi buku Beam Therapeutics|BEAM - Utang jangka dawa perusahaan|Utang jangka cendhak Beam Therapeutics|Rasio cepet beamtx.com
- statistik bathi lan rasio pasar:
BEAM - Penghasilan resik|Bathi resik mangsa ngarep Beam Therapeutics Inc.|BEAM - Pangali P/E|Kapitalisasi marang proyeksi bathi beamtx.com|BEAM - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Beam Therapeutics|BEAM - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Beam Therapeutics|BEAM - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan beamtx.com|BEAM - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Beam Therapeutics Inc.
Analisis kabeh metrik perusahaan:Beam Tx, BEAM
For the non-cyclical gene editing business of Beam Therapeutics Inc. (BEAM), the key factor is the ability to generate cash flow to cover expensive R&D costs. This indicator captures net operating income before depreciation, interest, and taxes, reflecting the real efficiency of capital management. By analyzing the EBITDA trend, an investor can assess the company's resilience to borrowing costs and the risks of potential drawdowns.
Karo sapa Beam Therapeutics Inc. saingan
Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TEM|QGEN: Bathi operasional sadurunge ngurangi amortisasi|ionispharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|RGEN: Bathi operasional EBITDA|Avidity Biosciences Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|CRSP (CRISPR Therapeutics Corp) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi GeneDx Corp WGS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ultragenyx Pharmaceutical (RARE)|SRPT (sarepta.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TWST (Twist Bioscience, Inc.)|Bathi operasional EBITDA 10x Genomics Inc TXG|NTLA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi STOK|BLFS: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi wavelifesciences.com (WVE)|Bathi operasional sadurunge ngurangi amortisasi MAZE|Bathi operasional EBITDA Sionna Therapeutics, Inc.|Bathi operasional sadurunge ngurangi amortisasi PRME (Prime Medicine Corp)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TSHA|Bathi operasional EBITDA QURE (uniQure N.V.)|Pendapatan operasional sadurunge ngurangi amortisasi meiragtx.com (MGTX)|REGENXBIO - Bathi operasional EBITDA|Solid Biosciences Inc (SLDB) - Bathi operasional sadurunge ngurangi amortisasi|Ocugen Corp (OCGN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PACB - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi BNTC|DSGN: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA RCKT|Pendapatan operasional sadurunge ngurangi amortisasi 4DMT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lexeo Therapeutics, Inc. LXEO|KRRO: Bathi operasional sadurunge amortisasi|Editas Medicine, Inc. - Bathi operasional EBITDA|silence-therapeutics.com (SLN) - Bathi operasional sadurunge ngurangi amortisasi|PRQR (proqr.com) - Bathi operasional sadurunge ngurangi amortisasi|CDXS - Pendapatan operasional sadurunge ngurangi amortisasi|SGMO (Sangamo) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAUT|Bathi operasional EBITDA MGX|DTIL - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi operasional EBITDA GBIO (Generation Bio)|Bathi operasional EBITDA Boundless Bio Inc. BOLD|XCUR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Imunon, Inc. (IMNN) - Bathi operasional sadurunge ngurangi amortisasi|PHIO: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi MBIO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics Inc.|Bathi operasional sadurunge amortisasi BNGO (Bionano)|Bathi operasional EBITDA APDN|Bathi operasional EBITDA bluebird bio, Inc (BLUE)|Bathi operasional EBITDA IPA (ImmunoPrecise Antibodies Ltd.)|omegatherapeutics.com - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Singular Genomics - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Regulus Therapeutics, Inc.|SYRS: Bathi operasional EBITDA|Telesis Bio, Inc (TBIO) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TRACON Pharmaceuticals|Bathi operasional sadurunge ngurangi amortisasi unitybiotechnology.com (UBX)
